Schedule ⇽ HTRS 2025 Scientific Symposium | Hemostasis & Thrombosis Research Society, Inc. (HTRS)

・8 characters minimum
・one upper case letter
・one lower case letter
・one number
・one special character (@$!%*?&)

Schedule

DAY 1: THURSDAY, MARCH 13, 2025

9:00 AM - 6:00 PM

Registration & Speed Poster Presentations – On Demand Viewing Area

9:00 AM - 10:00 AM

Puppy Yoga | Sponsored by Sanofi

Open to All Full-Conference Attendees, Space is Limited

10:30 AM - 11:30 AM

First Time Attendee Welcome Session

(Open to all new members)

11:00 AM - 1:00 PM

HTRS | FWGBD Sickle Cell Disease Research Roundtable

Pre-Registered Full-Conference Attendees Only, Space is Limited

11:30 AM - 1:00 PM

Riding the wave – Evolving approaches to an broad treatment landscape in hemophilia | Sponsored by Sanofi

General Session; Open to All Full-Conference Attendees

Join Dr. Sanjay Ahuja and a multidisciplinary panel as they dive into the latest advancements in hemophilia treatment. Discover firsthand how comprehensive care is evolving to meet new challenges and elevate treatment goals.

Elevate Your Hemophilia Practice: Join Our Multidisciplinary Panel Discussion

Overview and Objectives

Join us for a dynamic presentation and panel discussion to advanced hemophilia care practices. Our expert panel will explore:

The evolving hemophilia treatment landscape.
Expanding care goals beyond bleed management to include quality of life.
The potential impact of new and emerging therapies on comprehensive care and patient conversations.

Session Highlights

Current and Emerging Therapies: Understand the latest treatment approaches.
Comprehensive Care Goals: Focus on patient-specific factors like pain, activity, and quality of life.
Underserved Populations: Address the needs of women, the aging population, and those with comorbidities.
Mental Health: Learn about the psychological impact of hemophilia and the role of mental health professionals.
Patient and Caregiver Attitudes: Discuss how treatment advancements influence decisions.

Speaker: Dr. Sanjay Ahuja

11:30 AM - 1:00 PM

HTRS Board of Directors Lunch Meeting

(Board Members Only)

1:00 PM - 1:05 PM - Transition Time to Day 1 Opening Remarks and Scientific Session 1

1:05 PM - 1:10 PM - Day 1 Opening Remarks

1:10 PM - 2:25 PM

Scientific Session 1: Plenary Session

State-of-the-Art Lecture: "The Arrival of Gene Therapy"

Current landscape and future directions in gene therapy from bench to bedside

Moderators: Benjamin J. Samelson Jones, MD & Suman Sood, MD, MS

Speakers:

Glenn Pierce, MD, PhD
Lindsey A. George, MD

2:25 PM - 2:30 PM - Transition Time to Scientific Session 2

2:30 PM - 4:00 PM

Scientific Session 2: "Advancements in Hemostasis and Thrombosis: From Biochemistry to Clinical Practice - I"

Three (3) Concurrent Sessions:

2-A: New Discoveries in Coagulation Biochemistry

Recent discoveries in the biochemistry of coagulation and its regulation

Moderators: Alan E. Mast, MD, PhD & Gowthami M. Arepally, MD

Speakers:

Rodney M. Camire, PhD
Erica Sparkenbaugh, PhD
Karl C. Desch, MD

2-B: Pediatric Thrombosis: Challenges and Innovations

Challenges and innovations in pediatric thrombosis management

Moderators: Ayesha Zia, MD & Shreya Agarwal, MD

Speakers:

Jennifer Davila, MD
Marisol Betensky, MD, MPH
Susan Knight PT, PCS

2-C: Improving Care: The Advance Practice Provider and Multidisciplinary Professionals

Approaches to improving care for individuals with hemostatic and thrombotic disorders

Moderators: Eman Abdelghani, MD & Julia C. Hews-Girard, PhD, RN

Speakers:

Kelly Tickle, DNP, PCNS-BC, PPCNP-BC, EBP-C
Stacie Akins, PT, MHS
Ashlee Homer, MSN, MBA, RN
Timothy Schardt, PharmD, BCPS

4:00 PM - 4:30 PM

Afternoon Break

4:30 PM - 6:00 PM

Scientific Session 3: "Advancements in Hemostasis and Thrombosis: From Biochemistry to Clinical Practice - II"

Three (3) Concurrent Sessions:

3-A: Platelet Function and Dysfunction

Facets of platelet biology and clinical pathology; insights into the latest advancements in the field

Moderators: Robert Campbell, PhD & Michele P. Lambert, MD

Speakers:

Bhavya S. Doshi, MD
Craig Morrell, DVM, PhD
A. Valance Washington, PhD

3-B: Thrombosis: New Understanding and Novel Therapeutics

Insights into cutting-edge thrombosis research, clinical presentations, molecular mechanisms, and innovative therapies

Moderators: Timothy Stalker, PhD & Jessica C. Cardenas, PhD

Speakers:

Konstatine Halkidis, MD, PhD
Laurent Mosnier, PhD
Evi X. Stavrou, MD

3-C: Hemophilia Management in the Age of Non-Factor Treatments

Explore the evolving landscape of hemophilia management, focusing on the era of non-factor treatments and their molecular pathways

Moderators: Michael Wang & Beverly A. Schaefer, MD

Speakers:

Patrick Ellsworth, MD
Heidi D. Lane, PT, DPT, PCS
Maureane Hoffman, MD, PhD

6:00 PM - 7:30 PM

Welcome Reception

Exhibit Tent; Open to All Attendees

7:30 PM - 8:30 PM

Networking Event: Best of HTRS – "Meet Our Awardees" | Sponsored by Genentech

Speed Networking Session featuring Award Recipients (Abstract Awards, Student Research Awards, Mid-Career Research Award, etc.)

8:30 PM - 10:00 PM

HYMPAVIZ Now Approved: Learn about a new treatment for Hemophilia along with real-life patient experience on HYMPAVZI | Sponsored by Pfizer

One General Session Open to All Full-Conference Attendees

Presentation on MOA, Phase 3 clinical trial data, OLE, Dosing and Administration, Access Support for HYMPAVZI. In addition there will be a patient case study discussed.

Speaker: Dr. Akshat Jain, Loma Linda University Health

10:00 PM

Day 1 Concludes

Schedule

DAY 2: FRIDAY, MARCH 14, 2025

7:00 AM - 7:00 PM

Registration & Speed Poster Presentations – On Demand Viewing Area

7:00 AM - 8:00 AM

Real-World Management of Hemophilia A & B Across Life Stages | Sponsored by Sanofi

Concurrent Session; Open to All Full-Conference Attendees

Join us for an interactive exploration of hemophilia A and B case presentations, presented by expert speakers. Through rotating poster-style presentations we will explore real-world cases of success navigating changing life phases and patient priorities.

Speakers: Doris Quon, MD, PhD, Vanessa Salinas, MD, Candace DeBerry, ARNP-C, Maissaa Janbain, MD

Learn More About HYMPAVZI| Sponsored by Pfizer

Concurrent Session; Open to All Full-Conference Attendees

In this session, experts will discuss the product profile of Now Approved HYMPAVZI and discuss potential patient profiles.

8:00 AM - 8:05 AM - Transition Time to Day 2 Opening Remarks and Scientific Session 4

8:05 AM - 8:10 AM - Day 2 Opening Remarks

8:10 AM - 9:30 AM

Scientific Session 4: Plenary Session

"Voices from the Frontline: Patient Experiences, Clinical Care, and Research Insights in Hemostasis and Thrombosis"

Firsthand experiences and insights from patients living with disorders of hemostasis and thrombosis, with context and clinical expertise from their physicians

Moderators: X. Long Zheng, MD, PhD, and Rae Kerlin, MT (ASCP), NCA

Panelists

Bryce Kerlin, MD, FAAP and Vanessa Inuzuka
Spero R. Cataland, MD and Heather Money
Stefanie Dugan, MS, CGC and Sara Podejko
Andrew D. Leavitt, MD and Bobby Wiseman, Jr., MDiv

9:30 AM - 10:30 AM

Networking Session

Five (5) concurrent sessions. Choose one (1) to attend or network with Exhibitors in the Exhibit Hall.

Researchers' Roundtable - Open to all MD/PhDs, PhDs, post-docs, and discovery-based scientists
Advanced Practice Providers - Open to all nurses, nurse practitioners, physician assistants, pharmacists, social workers, etc.
Clinical Fellows Network - Open to all students and trainees
Industry Funding and Career Opportunities - Open to all conference attendees
ConECCTOR Network - Open to all junior faculty
Clinical Fellows Network - Open to all students and trainees

10:30 AM - 11:00 AM

Afternoon Break | Exhibits

Exhibit Tent

11:00 AM - 12:30 PM

Scientific Session 5: Plenary Session

"AI in Science and Medicine: Hype or Hope? A Conversation on Machine Learning's Role in Shaping the Future"

Lively and interactive conversation on the transformative potential of artificial intelligence (AI) and machine learning (ML) in science and medicine. Real-world applications, benefits, and limitations of AI technologies in these fields

Moderators: Jill Kirsch Jemison, MBA, and Alisa Wolberg, PhD

Speakers:

Timothy B. Plante, MD
Keith Neeves, PhD

12:30 PM - 2:00 PM

A Legacy in the Making: Experts Discuss Long-Term Outcomes and Clinical Impact of a Subcutaneous Prophylaxis Treatment in Hemophilia A | Sponsored by Genentech

Open to pre-registered full-conference attendees

Please join us for a thought-provoking discussion between experts Maya Bloomberg and Lynn Malec as they share their perspectives on the evolution of hemophilia A management and the impact of a subcutaneous prophylaxis treatment with over a decade of clinical trial experience. The presentation will include pivotal efficacy and safety data, long-term data, and a discussion on experts' clinical practice experience. Please bring your questions to have them answered live by experts in the Q&A following the program.

Speaker: Lynn Malec, MD, MSc; Senior Medical Director, Versiti Comprehensive Center for Bleeding Disorders

2:00 PM - 3:00 PM

Poster Session #1 | Exhibits

Exhibit Tent

Thrombosis/Inflammation 1

Roberto Aiolfi

Iva Pruner

Saravanan Subramaniam

Ashlyn E. Lowery

Hemostasis 1

Kyumin Lee, BS

Woosuk S. Hur

Jordan E. Ulsh, BS

Robert H. Lee, PhD

Clinical Hemostasis 1

Margareth C. Ozelo, MD, PhD

Lynn M. Malec, MD, MSc

Ayobami Olafimihan, MD

Karen Thibaudeau

Larissa Bornikova

Callie Berkowitz

Simon B. Bechara, MD

Cecilia Marquez-Gomez, MD

Tammuella Chrisentery-Singleton

Maeve S. McNamara

Maya Bloomberg, MSN, APRN, FNP-BC – Abstract Awardee

Susan Lattimore

Maria I. Barrett

Radhika Gangaraju, MD, MSPH

Shailly Gaur

Janice Staber, MD – Abstract of Distinction

Prachi Shah

Hunter Montgomery, BA

Annette Von Drygalski, MD

Leah M. Bruno, MD

Wolfgang Miesbach

Vlady Ostrow, DO

Hassan Ali

Zoey I. Harris, MD

Adam Cuker, MD, MS

Morgan Buchanan, MPH

Rachel S. Kronenfeld, MD

Elle M. Fukui, MD

Mindy Simpson

Emily Waters

William G. Mitchell, MD, MS

Clinical Thrombosis 1

Abhinav Rajasekhar

Youjin Oh

Simon Bechara, MD

Antonia Chan

Kristen Sanfilippo, MD, MPHS

Alexandra Forman

Ming Y. Lim, MBBCh, MS

Ying Lee

Joshua P. Muniz, MD

Katherine Armstrong, MD

Nicole DeMarco, DO

Bibi Maryam, MD

Nikhil Vojjala

Lena Ayari

Cheyennae Barbee

3:00 PM - 4:00 PM

Coffee Break | Exhibitor Spotlights

Exhibit Tent

4:00 PM - 5:30 PM

Scientific Session 6: Oral Abstract Presentations

Three (3) concurrent sessions: Choose 6-A, 6-B, or 6-C

6-A: Coagulation and Fibrinolysis

Moderator: Matthew J. Flick, PhD, and Jordan E. Ulsh, BS

Abstract Presenters:

Marissa Brake, PhD –Abstract Awardee
Zimu Wei, PhD
Indranil Biswas, PhD
Yaqiu Sang, PhD
Lakmali M. Silva, PhD
Timothy Stalker, PhD

6-B: Preclinical Models of Inflammation and Thrombosis

Moderator: Audrey Cleuren, PhD, and Roberto Aiolfi, PhD

Abstract Presenters:

Amrita Sarkar, PhD – Abstract Awardee
Tomasz W. Kaminski, PhD – Abstract Awardee
Catherine Lapointe, PhD – Abstract Awardee
Michelle Brenner, DO
Nirupama Ramadas, PhD
Jacob G. Ludington, MD, PhD

6-C: Clinical Thrombosis

Moderator: A. Koneti Rao, MBBS/MBBCh, and William Mitchell, MD

Abstract Presenters:

Cho Han Chiang, MD –Abstract Awardee
Madeline Young, BS –Abstract Awardee
Scott C. Woller, MD
Mrinalini Ramesh, DO/Resident –Abstract Awardee
Elizabeth Andekian, APNP –Abstract Awardee
Shreya Agarwal, MD

5:30 PM - 5:35 PM - Transition time to Scientific Session 7

5:35 PM - 7:05 PM

Scientific Session 7: "It's Time to Play "Radio HTRS"

Three (3) concurrent sessions: Choose 7-A, 7-B, or 7-C

7-A: HTRS Does "Science Friday"

Female K99/R00 researchers discuss challenges in obtaining funding, navigating faculty roles, and setting up research labs

Moderators: Robert H. Lee, PhD and Jordan Shavit, MD, PhD

Speakers

Lauren Poole, PhD
Lakmali Silva, PhD
Glaivy Batsuli, MD

7-B: HTRS Does "All Things Considered"

A multidisciplinary session offering practical insights and considerations for implementing and advancing gene therapy practices

Moderators: Kyme Groller, RN, and Jennifer L. Borrillo, LCSW

Speakers

Kim Schafer, MSN, FNP-C
Kat Molitor, MSN, AGCNS-BC, RN, CCRC
Amy K. Wilson, LICSW

7-C: HTRS Does "Wait Wait Don't Tell Me"

A multidisciplinary session on the pathophysiology, diagnosis, and management of hemostatic disorders in pregnancy and reproductive health

Moderators: Juliana Perez Botero, MD, and Eric Mullins, MD

Speakers

Maureen Katherine Baldwin, MD, MPH
Arran Seiler, MD
Rachel Rosovsky, MD, MPH

7:05 PM - 8:05 PM

Networking Reception | Tabletop Exhibit Spotlights

Exhibit Tent

8:05 PM - 8:30 PM

Check-In and Departure for HTRS Awards Dinner Cruise

Separate ticket required to attend

8:30 PM - 10:30 PM

EVENING EVENT | HTRS Awards Dinner Cruise aboard the California Spirit

Featuring live band karaoke

Separate ticket required to attend

10:30 PM

Day 2 Concludes

Schedule

DAY 3: SATURDAY, MARCH 15, 2025

7:00 AM - 11:30 AM

Registration & Speed Poster Presentations – On Demand Viewing Area

7:00 AM - 8:00 AM

Explore a new treatment option for your patients with hemophilia with inhibitors | Sponsored by Novo Nordisk, Inc.

Concurrent Session; Open to All Full-Conference Attendees

Hemophilia is a rare, lifelong bleeding disorder that requires ongoing care. Replacement therapy with clotting factor concentrates is the most common treatment for people with hemophilia A or hemophilia B. However, patients may develop alloantibodies, or inhibitors, that make factor replacement therapy ineffective. This is one of the most serious complications of treatment for patients with hemophilia. While there have been advances in the treatment options for people with hemophilia A with inhibitors, there remains a need for additional prophylactic non-factor therapy options, especially for people with hemophilia B with inhibitors. This program will provide information on a new prophylactic treatment option for people with hemophilia A and hemophilia B with inhibitors and share results from the clinical trial.

Speaker: Amy Shapiro, MD; Medical Director and CEO, Indiana Hemophilia and Thrombosis Center

Real-World Experience With Gene Therapy for Adults with Hemophilia B: An Expert Panel Presentation | Sponsored by CSL Behring

Concurrent Session; Open to All Full-Conference Attendees

In 2022, the FDA approved the first-ever gene therapy for adults with hemophilia B. Join us for an engaging

panel presentation and discussion featuring Stephanie Ambrose, DO, and Aimee Foord, DO, as they highlight long-term (4-year) data and share their real-world experience with the gene therapy.

Continuing education credits will not be offered for this program.

Speakers: Vidhi Desai, MD; Senior Medical Director, Coagulation, CSL Behring | Stephanie Phillips Ambrose, DO; Medical Director, South Carolina Hemostasis and Thrombosis Center Section Chief, Pediatric Nonmalignant Hematology, Prisma Health; Aimee Foord, DO; Director, Bleeding and Clotting Clinics, Attending Physician Pediatric Hematology Oncology, Cure 4 The Kids Foundation

8:00 AM - 8:05 AM - Transition Time to Day 2 Opening Remarks and Scientific Session 4

8:05 AM - 8:10 AM - Day 2 Opening Remarks

8:10 AM - 9:40 AM

Scientific Session 8: Oral Abstract Presentations

Three (3) concurrent sessions: Choose 8A, 8B, or 8C

8-A: Platelets and Megakaryocytes - Basic and Translational

Moderator: James H. Morrissey, PhD, and Natthapol Songdej, MD, MPH

Abstract Presenters

Qizhen Shi, MD, PhD – Abstract of Distinction
Mariia Kumskova, MD – Abstract Awardee
Izabella Andrianova, PhD
Eric F. Grabowski, MD
Madison Shay, PhD Student – Abstract Awardee
Gowtham Amarapu, PhD

8-B: Coagulation Disorders

Moderator: Karin Leiderman, PhD, and Zoey Harris, MD

Abstract Presenters

Silvia Juarez Rojas, BA – Abstract Awardee
Ming Y. Lim, MBBCh, MS
Stéphanie Reitsma, PhD
Maria Santaella, PhD, MSN, RN-BC – Abstract Awardee
Brian Branchford, MD
Riley M. Wimberley, BS

8-C: Industry/Clinical Trails

Moderator: Guy Young, MD, and Abhinav Rajasekhar

Abstract Presenters

Vlady Ostrow, DO
Christopher J. Czura, PhD
Margareth C. Ozelo, MD, PhD
Caroline Berube, MD
Allison Wheeler, MD
Vilmarie Rodriguez, MD, MS

9:40 AM - 10:00 AM

Morning Break

10:00 AM - 11:30 AM

Scientific Session 9: "Unraveling the Controversies: Innovative Discussions in Hemostasis and Thrombosis"

Two (2) concurrent sessions: Choose 9-A or 9-B

9-A: "Clinical Conundrums: Expert Insights on Hemostasis and Thrombosis Management"

Presenters pose clinical conundrums to the audience, inviting active participation in unraveling complex issues in hemostasis and thrombosis management

Moderators: Mark Crowther, MD, and Meera Sridharan, MD, PhD

Speakers

Shannon Meeks, MD, MBA
Char Witmer, MD, MSCE
Gary Woods, MD

9-B: "Advancing Science: Expert Insights on Coagulation Research"

Presenters will engage the audience in discussions on advancing coagulation research, focusing on rigor and reproducibility in various aspects of scientific investigation

Moderators: Joshua Muia, PhD, and Lacra Ivanciu, PhD

Speakers

Nigel Mackman, PhD
Frederik Denorme, PhD
Kellie Machlus, PhD

11:30 AM - 12:30 PM

Poster Session #2 | Exhibits

Exhibit Tent

Thrombosis/Inflammation 2

Tomasz W. Kaminski

Deepa Gautam, PhD

Praneetha Bheemarasetty, BS

Hemostasis 2

John J. Morris

Nishtha Pathak, MS

Karin Leiderman, PhD

Laurent Mosnier, PhD – Abstract of Distinction

Philip Olivares

Clinical Hemostasis 2

Emily Waters

Osman Khan, MD, MS

Anya Parekh

Frank Plonski

Michele P. Lambert, MD, MSTr

Mindy Simpson

Amy Chen

Elizabeth Palmer, MS, CGC, LCGC

Katherine Barry Ellis, PA-C

Tro Sekayan

Vrushali Pachpande, MD, MS

Sanober Nusrat

Beatriz Caceres-Nazario, MD

Eleanor Carrick, MA

Alexandra Noveihed

Tammuella Chrisentery-Singleton

Michael Tarantino, MD

Davide Matino

Junaid A. Wali, MBBS

Mark T. Reding, MD

Kristin T. Ansteatt, FNP-BC

Robert F. Sidonio Jr, MD, MSc

Saad A. Sidiq, DO

Lisa N. Boggio, MD

Brian Branchford, MD

Vlady Ostrow, DO

Megan C. Brown, MD, MSc

Clinical Thrombosis 2

Mrinal Ranjan

Emily Drake, MSN FNP

Manali H. Shah

Ayobami Olafimihan, MD – two posters

Thomas DeLoughery, MD

Maria F. Albuja Altamirano, MD

Mehul S. Thakkar, MD

Guy Young, MD

Sylvia Werner, MD, MBA, MSc

Bibi Maryam, MD

Zurwa Nishat

Aqsa Ashraf

Brianna R. Bakow, MD

Ghadeer K. Dawwas, PhD, MSc, MBA

Sarah Côté-Denis, BSc

Simon B. Bechara

Lisa Baumann Kreuziger, MD

12:30 PM - 12:40 PM

Closing Remarks

Exhibit Tent

12:40 PM - 1:30 PM

Closing Networking Reception

Exhibit Tent

1:30 PM

Day 3 Adjourns | HTRS 2025 Scientific Symposium Concludes

See you at HTRS 2027 from March 11-13, 2027 in Philadelphia, PA!

HTRS 2025 Scientific Symposium

When

Where

Organizer

Schedule

Schedule

Schedule

Schedule

Schedule

Print-Friendly Agenda

Schedule

Schedule

Schedule

Schedule

Schedule

Schedule